Vanotech Ltd Archives | Be Korea-savvy

Chengdu Origen and Vanotech Announce First Patient Dosed in VAN-2401 Phase 1 Trial of Gene Therapy for Wet Age-Related Macular Degeneration

Clinical trial of KH658 evaluates single suprachoroidal space administration of gene-therapy treatment for wet AMD CHENGDU, China and ROCKAWAY, N.J., May 02, 2025 (Korea Bizwire) – Chengdu Origen Biotechnology Co., Ltd. (“Chengdu Origen”) and Vanotech Ltd. (“Vanotech”) announced today the first patient dosed in the VAN-2401 multi-center Phase 1 clinical trial evaluating treatment with KH658 [...]

Vanotech Appoints Matthew Schiller to Lead Business Development

ROCKAWAY, N.J., March 13, 2025 (Korea Bizwire) – Vanotech Ltd, a pharmaceutical company devoted to greatly improving the lives of people living with Ophthalmic, central nervous, digestive and endocrine conditions using innovative science that results in breakthrough medicines, announced today that Matthew Schiller has been appointed as Head of Business Development. Mr. Schiller brings extensive leadership [...]